139 related articles for article (PubMed ID: 6821325)
1. Lysosomal storage diseases.
Brady RO
Pharmacol Ther; 1982; 19(3):327-36. PubMed ID: 6821325
[No Abstract] [Full Text] [Related]
2. An appraisal of human trials in enzyme replacement therapy of genetic diseases.
Tager JM; Hamers MN; Schram AW; Van den Bergh FA; Rietra PJ; Loonen C; Koster JF; Slee R
Birth Defects Orig Artic Ser; 1980; 16(1):343-59. PubMed ID: 6778527
[No Abstract] [Full Text] [Related]
3. Investigations in enzyme replacement therapy in lipid storage diseases.
Brady RO; Pentchev PG; Gal AG
Fed Proc; 1975 Apr; 34(5):1310-5. PubMed ID: 804420
[TBL] [Abstract][Full Text] [Related]
4. Genetic errors and enzyme replacement strategies.
Brady RO
Res Publ Assoc Res Nerv Ment Dis; 1983; 60():181-93. PubMed ID: 6130585
[No Abstract] [Full Text] [Related]
5. Enzyme therapy for inborn errors of metabolism.
Desnick RJ; Bernlohr RW; Krivit W
Postgrad Med; 1973 Jan; 53(1):214-6. PubMed ID: 4508960
[No Abstract] [Full Text] [Related]
6. Current enzyme replacement therapy for the treatment of lysosomal storage diseases.
Lim-Melia ER; Kronn DF
Pediatr Ann; 2009 Aug; 38(8):448-55. PubMed ID: 19725195
[No Abstract] [Full Text] [Related]
7. [Importance of the culture of cells in vitro for the diagnosis and study of metabolic diseases].
Esposito G
Pediatria (Napoli); 1971; 79(2):270-83. PubMed ID: 4255382
[No Abstract] [Full Text] [Related]
8. Cardiac involvement in inherited disorders of metabolism.
Blieden LC; Moller JH
Prog Cardiovasc Dis; 1974; 16(6):615-31. PubMed ID: 4207425
[No Abstract] [Full Text] [Related]
9. Diagnostic and therapeutic applications of sphingolipid hydrolyzing enzymes.
Brady RO
Curr Top Cell Regul; 1985; 26():39-50. PubMed ID: 3935381
[No Abstract] [Full Text] [Related]
10. Therapeutic approaches to selected disorders of inborn errors of metabolism with neurological involvement.
Dekaban AS; Brady RO
Int J Neurol; 1976; 11(1):46-61. PubMed ID: 828152
[No Abstract] [Full Text] [Related]
11. The genetic pathology of lysosomes.
Hers HG; Van Hoof F
Prog Liver Dis; 1970; 3():185-205. PubMed ID: 4985552
[No Abstract] [Full Text] [Related]
12. Haematological aspects of lipid storage diseases.
Brady RO
Acta Haematol Pol; 1977; 8(2):103-12. PubMed ID: 407769
[No Abstract] [Full Text] [Related]
13. ENZYMES IN MENTAL RETARDATION. II.
ROSANOVA AR; NEIMEYER H; COMPALL T; MICHAELSON AS
IMJ Ill Med J; 1964 Sep; 126():335-41. PubMed ID: 14199874
[No Abstract] [Full Text] [Related]
14. A new look at the inborn errors of metabolism.
Sinclair L
Ann Clin Biochem; 1982 Jul; 19 (Pt 4)():314-21. PubMed ID: 6812485
[No Abstract] [Full Text] [Related]
15. Toward enzyme therapy for lysosomal storage diseases.
Desnick RJ; Thorpe SR; Fiddler MB
Physiol Rev; 1976 Jan; 56(1):57-99. PubMed ID: 813242
[No Abstract] [Full Text] [Related]
16. Enzyme therapy in lysosomal storage diseases: current approaches.
Rattazzi MC
Prog Clin Biol Res; 1982; 103 Pt B():573-87. PubMed ID: 6219401
[No Abstract] [Full Text] [Related]
17. [Lysosomal storage diseases].
Manger B
Z Rheumatol; 2010 Aug; 69(6):527-38. PubMed ID: 20532791
[TBL] [Abstract][Full Text] [Related]
18. The lipid storage diseases: new concepts and control.
Brady RO
Ann Intern Med; 1975 Feb; 82(2):257-61. PubMed ID: 163609
[TBL] [Abstract][Full Text] [Related]
19. Serum enzymes and inborn errors of metabolism in man.
Schapira G; Dreyfus JC
Monogr Hum Genet; 1978; 9():227-30. PubMed ID: 104147
[No Abstract] [Full Text] [Related]
20. Liposomes in the therapy of lysosomal storage diseases.
Gregoriadis G
Nature; 1978 Oct; 275(5682):695-6. PubMed ID: 100708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
